Alcon Inc (ALC) reports a 5% increase in revenue, driven by robust performance in surgical and ocular health segments, despite facing margin challenges and tariff-related costs.

Q3 2025 Management View CEO David Endicott pointed to building momentum in the second half of 2025, with particular strength in equipment and ocular health. Endicott highlighted, "the launch [of Unity ...

The global eyecare company, with manufacturing and research facilities in Berks County, reduced its full-year projections in ...

Alcon, Inc. ALC delivered third-quarter 2025 core earnings per share (EPS) of 79 cents, down 2.5% from the year-ago quarter’s ...

Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum ...

Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) ...

Target Corp. is eliminating about 8% of corporate roles in its first major restructuring in years, according to a memo viewed by Bloomberg News, as the retailer seeks to reduce complexity and regain ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL), ...

Staar Surgical Co. today announced that the shareholder vote to determine if the Alcon deal moves forward was postponed until Nov. 6. The meeting, originally scheduled for today, was adjourned with no ...

Oct 22 (Reuters) - Medtech firm Staar Surgical's (STAA.O), opens new tab biggest investor, Broadwood Partners, is planning to call a shareholder meeting to remove several directors, it said on ...